The growing complexity of clinical trials has fuelled demand
for ePRO solutions that ease the burden of trial participation
for patients while building confidence in the quality and
accuracy of data for sponsors. Now playing in the ePRO
space, iCardiac is on a mission to bring together technology
and flexible supply strategies to create a modernising force
for today’s global trials. John Sage, Senior Vice President,
Respiratory & ePRO at iCardiac Technologies, Inc., talks to
Journal for Clinical Studies about the fast-evolving market, its
challenges and what the future holds.
 
 
https://www.jforcs.com/7/wp-content/uploads/2016/02/18-J107-2.pdf